MAZE logo

MAZE

Maze Therapeutics, Inc.NASDAQHealthcare
$28.71-1.17%ClosedMarket Cap: $1.43B

As of 2026-04-06

Insider Statistics (Q2 2026)

Purchases

2

Sales

7

Buy/Sell Ratio

0.29

Total Bought

$0.00

Total Sold

$5.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell15,000$10.42237,407
Thu Apr 02Bachrodt Amyofficer: SVP, FinanceSell300$30.3412,965
Thu Apr 02Bachrodt Amyofficer: SVP, FinanceSell2,200$29.3213,265
Thu Apr 02Bachrodt Amyofficer: SVP, FinanceSell2,500$10.4233,833
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell300$31.070
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell3,348$30.06300
Thu Apr 02Bernstein Haroldofficer: President, R&D & CMOSell11,352$29.243,648
Wed Apr 01Dandekar Atulofficer: CSBOSell7,500$10.4251,643
Wed Apr 01Dandekar Atulofficer: CSBOSell6,710$29.2611,293
Wed Apr 01Dandekar Atulofficer: CSBOSell790$30.0210,503
Tue Mar 31Kumar NeilSell0$0.000
Tue Mar 31Kumar NeildirectorSell33,417$30.3833,417
Fri Mar 20Bernstein Haroldofficer: President, R&D & CMOSell6,161$48.208,839
Fri Mar 20Bernstein Haroldofficer: President, R&D & CMOSell15,000$10.42252,407
Fri Mar 20Bernstein Haroldofficer: President, R&D & CMOSell3,795$49.325,044